Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianshui Li
Yan Pei

Showing results (331-340 of 342) with videos related to

Pageof 35
Sort By:
Nature Communications|March 4, 2023
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapyXue Bai, Ze-Qin Guo, Yan-Pei Zhang, et al.
Free Radical Biology & Medicine|February 21, 2026
Radiotherapy disrupts ferroptosis tolerance by reducing DNMT1 levels and uncouples STING silencing in LKB1-deficient lung tumorsYan-Pei Zhang, Fei-Fei Wu, Ze-Nan Wu, et al.
BMC Medicine|October 8, 2024
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort studyZi-Xuan Rong, Wei Wei, Qin Zeng, et al.
BMC Medicine|January 4, 2023
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validationXue-Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong, et al.
American Journal of Human Genetics|September 16, 2004
Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillationYiqing Yang, Min Xia, Qingfeng Jin, et al.
Cancer Research|December 13, 2022
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung CancerLi-Li Long, Si-Cong Ma, Ze-Qin Guo, et al.
BMC Medicine|April 12, 2022
Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practiceSi-Cong Ma, Xue Bai, Xue-Jun Guo, et al.
Plos Genetics|January 22, 2011
Genome sequencing and comparative transcriptomics of the model entomopathogenic fungi Metarhizium anisopliae and M. acridumQiang Gao, Kai Jin, Sheng-Hua Ying, et al.
Nature Cancer|March 5, 2026
CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-offSi-Cong Ma, Zi-Xuan Rong, Zi-Peng Xu, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|October 10, 2013
[Analysis of resistance tendency of bloodstream-infecting pathogens in China]Yuan Lü, Yun Li, Feng Xue, et al.
Pageof 35

Showing results (331-340 of 342) with videos related to

Sort By:
Pageof 35
Nature Communications|March 4, 2023
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapyXue Bai, Ze-Qin Guo, Yan-Pei Zhang, et al.
Free Radical Biology & Medicine|February 21, 2026
Radiotherapy disrupts ferroptosis tolerance by reducing DNMT1 levels and uncouples STING silencing in LKB1-deficient lung tumorsYan-Pei Zhang, Fei-Fei Wu, Ze-Nan Wu, et al.
BMC Medicine|October 8, 2024
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort studyZi-Xuan Rong, Wei Wei, Qin Zeng, et al.
BMC Medicine|January 4, 2023
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validationXue-Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong, et al.
American Journal of Human Genetics|September 16, 2004
Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillationYiqing Yang, Min Xia, Qingfeng Jin, et al.
Cancer Research|December 13, 2022
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung CancerLi-Li Long, Si-Cong Ma, Ze-Qin Guo, et al.
BMC Medicine|April 12, 2022
Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practiceSi-Cong Ma, Xue Bai, Xue-Jun Guo, et al.
Plos Genetics|January 22, 2011
Genome sequencing and comparative transcriptomics of the model entomopathogenic fungi Metarhizium anisopliae and M. acridumQiang Gao, Kai Jin, Sheng-Hua Ying, et al.
Nature Cancer|March 5, 2026
CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-offSi-Cong Ma, Zi-Xuan Rong, Zi-Peng Xu, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|October 10, 2013
[Analysis of resistance tendency of bloodstream-infecting pathogens in China]Yuan Lü, Yun Li, Feng Xue, et al.
Pageof 35